FDA Authorizes New Booster Shots Aimed at Omicron Subvariants

The Food and Drug Administration authorized newly modified Covid-19 booster shots to target the latest versions of the Omicron variant. The authorization, however, comes without a key part of the decision-making process. WSJ’s Daniela Hernandez explains what’s changed with these new booster shots. Photo: Laura Kammermann